Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.
about
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunctionTreatment options for hypertension in pregnancy and puerperium.Placental Nkx2-5 and target gene expression in early-onset and severe preeclampsia.Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort studyMaternal plasma soluble TRAIL is decreased in preeclampsia.Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.Placental lesions associated with acute atherosis.Preeclampsia - Aetiology, Current Diagnostics and Clinical Management, New Therapy Options and Future Perspectives.Association of maternal hypertensive disorders with retinopathy of prematurity: A systematic review and meta-analysisPrenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria.The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.Twin Chorionicity and the Risk of Hypertensive Disorders: Gestational Hypertension and Pre-eclampsia.Preeclampsia in twin pregnancies: association with selective intrauterine growth restriction.Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.Angiogenic factors: Potential to change clinical practice in preeclampsia?Adverse maternal outcomes and birth weight discordance in twin gestation: British Columbia, Canadian data.Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review.Skin capillary density in infants born to normotensive mothers: a comparison between singleton and twin infants.Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.Preeclampsia is associated with hypermethylation of IGF-1 promoter mediated by DNMT1.Placental Growth Factor Reverses Decreased Vascular and Uteroplacental MMP-2 and -9 and increased MMP-1 and -7 and Collagen I and IV in Hypertensive Pregnancy.
P2860
Q24201073-904500A3-93BF-40B5-A87C-B715B891C97DQ30244979-308087B6-CF35-448C-BA66-EFD97114BC6FQ30409774-E0F631F3-9CCA-4438-9BCC-AC644DE95BEDQ33897439-0DCB6FCB-7B4B-404B-9C01-585256C28FBEQ33909572-6FF3C7D3-054A-4815-8DBB-035C908FEC0FQ34619975-D5127F5C-19A8-4ED5-8457-D0EC2241F406Q34670424-F77E0510-4A6E-47F8-8D59-B3275113C35EQ35558666-896F2C60-AC37-48E0-82CF-5BDA097812F1Q36295102-A629FB32-7AED-46B1-838E-FBE93A1C7817Q36339840-3D2884ED-36B0-43FF-A4F0-8B38B5AAEF8AQ37395519-D9DF70DC-9170-40FA-97B4-783BB0BF9BF4Q37597482-7663093B-E0EA-4C3F-B70C-DD70108C30C7Q39781705-FA1755A9-00A4-49FC-816C-2CD731D41429Q40742868-0E8AB28A-E4F2-49D6-A6FD-01B622299F03Q41033848-F52393B1-DACE-46CE-A399-B3E725944294Q41709450-12FA12D3-1937-45A1-8DFF-9594D20D86CCQ46301113-18F64BCA-E502-4520-8FC7-3044764D41B7Q47137877-1CA6ED17-E57C-40A1-8509-E699911553D3Q47154280-4223463B-05CE-4363-B033-39E31109500BQ47549903-8D14DC03-1BA0-4532-9F66-4683F751704CQ47799852-33C6C23E-21E8-47EE-B28A-E84741C4418FQ49312791-F2CEE5B1-8A2A-429A-8ED8-56D8AB37405CQ50105894-DFC01A1F-EE8A-48CB-AD4D-11AF797DB69CQ54119733-E9A2940F-0E06-4802-8D03-DF8308FE982D
P2860
Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Circulating angiogenic factors ...... s with suspected preeclampsia.
@ast
Circulating angiogenic factors ...... s with suspected preeclampsia.
@en
type
label
Circulating angiogenic factors ...... s with suspected preeclampsia.
@ast
Circulating angiogenic factors ...... s with suspected preeclampsia.
@en
prefLabel
Circulating angiogenic factors ...... s with suspected preeclampsia.
@ast
Circulating angiogenic factors ...... s with suspected preeclampsia.
@en
P2093
P2860
P50
P1433
P1476
Circulating angiogenic factors ...... s with suspected preeclampsia.
@en
P2093
Frank H Perschel
Kee-Hak Lim
Saira Salahuddin
Sarosh Rana
P2860
P304
P356
10.1161/HYPERTENSIONAHA.112.195065
P407
P577
2012-07-02T00:00:00Z